Codeine O‐demethylation co‐segregates with polymorphic debrisoquine hydroxylation.
Open Access
- 1 December 1989
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 28 (6) , 639-645
- https://doi.org/10.1111/j.1365-2125.1989.tb03556.x
Abstract
1. A single oral dose of codeine (25 mg) was given to 132 healthy Swedish Caucasians who had previously been phenotyped with respect to debrisoquine hydroxylation. The ‘metabolic ratios’ (MR) in urine of codeine O-demethylation (codeine/(morphine (M) + morphine-3- and 6- glucuronides (M3G and M6G) + normorphine], N-demethylation (codeine/(norcodeine (NC) + norcodeine glucuronide + normorphine (NM]) and glucuronidation (codeine/codeine-6-glucuronide (C6G] were calculated following h.p.l.c. analysis of urine samples collected over 8 h. 2. There was a significant correlation between the log MR for debrisoquine hydroxylation and the log MR for codeine O-demethylation (rs = 0.77, P less than 0.001). The poor debrisoquine hydroxylators had MRs of codeine O-demethylation between 8.3 and 55.1, while the values for extensive hydroxylators were between 0.4 and 5.5. 3. The poor debrisoquine hydroxylators excreted significantly less M, M3G, M6G and NM, while the urinary recovery of C6G and NC was significantly higher in these subjects compared to the extensive hydroxylators. 4. The MRs for glucuronidation and N-demethylation did not exhibit a bimodal distribution, and were not related to the MR of debrisoquine hydroxylation. 5. No associations were found between sex, body-weight, smoking habits, age, urine volume or urine pH and the O-demethylation of codeine. 6. The O-demethylation of codeine to form M appears to be under the same polymorphic genetic control as the 4-hydroxylation of debrisoquine.This publication has 30 references indexed in Scilit:
- Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Published by Elsevier ,2005
- POLYMORPHIC O-DEMETHYLATION OF CODEINEThe Lancet, 1988
- ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDEThe Lancet, 1988
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Morphine-6-glucuronide: Analgesic effects and receptor binding profile in ratsLife Sciences, 1988
- Cytochrome P450 gene expression and regulationTrends in Pharmacological Sciences, 1985
- Human cytochromes P-450Xenobiotica, 1984
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Tolerance and Side Effects During Long Term Treatment of Hypertension with DebrisoquineAustralian and New Zealand Journal of Medicine, 1972